| Fondaparinux | Enoxaparin | UFH | Others | Medication (-) | Total |
---|---|---|---|---|---|---|
n = 360 (%) | n = 223 (%) | n = 72 (%) | n = 45 (%) | n = 594 (%) | n = 1,294 (%) | |
All venous thromboembolism | 61 (16.9) | 59 (26.5) | 24 (33.3) | 12 (26.7) | 158 (26.6) | 314 (24.3) |
  Any DVT (up to POD10 ) | 60 (16.7) | 59 (26.5) | 24 (33.3) | 12 (26.7) | 158 (26.6) | 314 (24.3) |
  Symptomatic DVT | 2 (0.6) | 3 (1.3) | 0 | 1 (2.2) | 6 (1.0) | 12 (0.9) |
   Distal | 1 (0.3) | 2 (0.9) | 0 | 1 (2.2) | 4 (0.7) | 8 (0.6) |
   Proximal | 1 (0.3) | 1 (0.4) | 0 | 0 | 2 (0.3) | 4 (0.3) |
  Non-symptomatic DVT | 59 (16.4) | 56 (25.1) | 24 (33.3) | 11 (24.4) | 152 (25.6) | 302 (23.3) |
   Distal | 51 (14.2) | 52 (23.3) | 21 (29.2) | 11 (24.4) | 133 (22.4) | 268 (20.7) |
   Proximal | 8 (2.2) | 4 (1.8) | 3 (4.2) | 0 | 19 (3.2) | 34 (2.6) |
  PE (up to POD28) | 1 (0.3) | 0 | 0 | 0 | 1 (0.2) | 2 (0.2) |